Skip content
Equine

Equine

Equine

pain-management

Altren® (Altrenogest)

Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Get Aurora

pain-management

Altren® (Altrenogest)

Package Presentation

1,000 mL Bottle

Reorder No: 28006

150 mL Bottle

Reorder No: 28007

Get Aurora

Product
Features

  • Use to schedule estrus in mares and breeding in mares to maximize breeding efficiency
  • Available in 1000 mL and 150 mL bottles along with FDA-approved vented draw-off cap. Administer orally with dose syringe or by placing directly on feed
  • Provides safe, effective suppression of estrus in mares – 95% effective after 3 days of treatment
  • The same active ingredient and strength as Regu-Mate®, altrenogest 2.2 mg/mL.
  • Approved by FDA under ANADA 200-620
  • Manufactured under GMP standards for quality and consistency

Regu-Mate is a Registered Trademark of Merck Animal Health.

Safety
Info

Altren® (Altrenogest) is contraindicated for use in mares having a previous or current history of uterine inflammation. Natural or synthetic gestagen therapy may exacerbate existing low-grade or “smoldering” uterine inflammation into a fulminating uterine infection in some instances. Do not use in horses intended for human consumption.

Avoid skin contact. Altren® is absorbed through unbroken skin, and exposure may result in serious side effects to both women and men. Wear vinyl, neoprene, or nitrile gloves when handling or administering Altren® (Altrenogest), or when touching contaminated surfaces or equipment. Latex gloves are not protective. PREGNANT WOMEN OR WOMEN WHO MAY BE PREGNANT SHOULD NOT HANDLE ALTREN®. WOMEN OF CHILDBEARING AGE SHOULD EXERCISE EXTREME CAUTION WHEN HANDLING THIS PRODUCT.

Altren® (Altrenogest) is readily absorbed through the skin and could lead to a disruption of the menstrual cycle or prolongation of pregnancy. People who should not handle this product include those with thrombophlebitis, thromboembolic disorders, or with a history of these events, cerebral-vascular or coronary-artery disease, suspected estrogen-dependent neoplasia, benign or malignant tumors which developed during the use of oral contraceptives or other estrogen containing products, liver dysfunction or disease, and women with known or suspected carcinoma of the breast or undiagnosed vaginal bleeding. Accidental spillage on the skin should be washed off immediately with soap and water. Keep out of the reach of children. For complete safety information, refer to the package insert.

PRECAUTIONS:
Various synthetic progestins, including altrenogest, when administered to rats during the embryogenic stage of pregnancy at doses manyfold greater than the recommended equine dose caused fetal anomalies, specifically masculinization of the female genitalia.

WARNINGS:
Altren® (Altrenogest) is readily absorbed by the skin. Skin contact must be avoided; protective gloves must be worn when handling this product. Not for use in humans. Keep out of reach of children. Altren® (Altrenogest) is absorbed through unbroken skin, and exposure may result in serious side effects to both women and men.

Safety
Info

Altren® (Altrenogest) is contraindicated for use in mares having a previous or current history of uterine inflammation. Natural or synthetic gestagen therapy may exacerbate existing low-grade or “smoldering” uterine inflammation into a fulminating uterine infection in some instances. Do not use in horses intended for human consumption.

Avoid skin contact. Altren® is absorbed through unbroken skin, and exposure may result in serious side effects to both women and men. Wear vinyl, neoprene, or nitrile gloves when handling or administering Altren® (Altrenogest), or when touching contaminated surfaces or equipment. Latex gloves are not protective. PREGNANT WOMEN OR WOMEN WHO MAY BE PREGNANT SHOULD NOT HANDLE ALTREN®. WOMEN OF CHILDBEARING AGE SHOULD EXERCISE EXTREME CAUTION WHEN HANDLING THIS PRODUCT.

Altren® (Altrenogest) is readily absorbed through the skin and could lead to a disruption of the menstrual cycle or prolongation of pregnancy. People who should not handle this product include those with thrombophlebitis, thromboembolic disorders, or with a history of these events, cerebral-vascular or coronary-artery disease, suspected estrogen-dependent neoplasia, benign or malignant tumors which developed during the use of oral contraceptives or other estrogen containing products, liver dysfunction or disease, and women with known or suspected carcinoma of the breast or undiagnosed vaginal bleeding. Accidental spillage on the skin should be washed off immediately with soap and water. Keep out of the reach of children. For complete safety information, refer to the package insert.

PRECAUTIONS:
Various synthetic progestins, including altrenogest, when administered to rats during the embryogenic stage of pregnancy at doses manyfold greater than the recommended equine dose caused fetal anomalies, specifically masculinization of the female genitalia.

WARNINGS:
Altren® (Altrenogest) is readily absorbed by the skin. Skin contact must be avoided; protective gloves must be worn when handling this product. Not for use in humans. Keep out of reach of children. Altren® (Altrenogest) is absorbed through unbroken skin, and exposure may result in serious side effects to both women and men.

Cookies & Privacy

Our website uses cookies. By using our website and agreeing to this policy, you consent to our use of cookies in accordance with our Privacy Policy and our Terms and Conditions.